Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
2010 · New England Journal of Medicine · 5,521 citations
https://doi.org/10.1056/nejmoa0909530
S
Satoshi Oizumi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
305
Papers
12.4K
Citations
42
h-index
109
i10-index
Satoshi Oizumi is an academic researcher. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Lung Cancer Diagnosis and Treatment. The author has an h-index of 42, co-authored 260 publications.
ORCID: 0000-0002-9742-1818Papers by this author
worksAnalysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702)
2019 · The Oncologist · 61 citations
https://doi.org/10.1634/theoncologist.2018-0676
Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer
2013 · Radiation Oncology · 52 citations
https://doi.org/10.1186/1748-717x-8-69
γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer
2012 · British Journal of Cancer · 48 citations
https://doi.org/10.1038/bjc.2012.178
Anaplastic transformation of papillary thyroid carcinoma in multiple lung metastases presenting with a malignant pleural effusion: a case report
2014 · Journal of Medical Case Reports · 22 citations
https://doi.org/10.1186/1752-1947-8-460
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non–Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)
2020 · Clinical Lung Cancer · 22 citations
https://doi.org/10.1016/j.cllc.2020.09.023
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat